Scientists from Nanyang Technological University (NTU) have developed an antibody with the potential to help patients suffering from pneumonia and influenza to recover faster, the varsity said in a news release on Tuesday (Feb 10).
The scientists – from NTU’s School of Biological Sciences, Institute of Molecular and Cell Biology, National University of Singapore (NUS) and doctors from National University Health System – are now using the antibody to develop a diagnostic kit. The kit can help doctors accurately track the recovery progress of flu and pneumonia patients.
NTU added that while the antibody has proven effective in lab tests, more research needs to be done before the antibody can be safely tested in humans.
Two biotech multinationals, Abcam and Adipogen International, have won rights to license the antibody, said NTU. The antibody will be produced for sale to global organisations doing research in vaccine and drug development.